Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fungal cell wall and cell membrane are essential protective structures that maintain the viability and shape of fungal cells. The cell wall is a rigid outer layer composed of chitin, beta-glucans, and mannoproteins, providing osmotic stability and protection against environmental stress (StatPearls: Antifungal Medications; NCBI: Fungal Cell Wall). Beneath the wall lies the cell membrane, a lipid bilayer where ergosterol serves as the primary sterol, regulating fluidity and the function of membrane-bound proteins (NIH: Ergosterol as an Antifungal Target). Because these structures contain components absent in human cells, such as beta-glucans and ergosterol, they are primary targets for antifungal therapy (PubChem: Fluconazole Mechanism). Echinocandins disrupt the cell wall by inhibiting 1,3-beta-glucan synthase, while polyenes like amphotericin B bind to ergosterol to create lethal pores in the membrane (StatPearls: Antifungal Medications; Wikipedia: Antifungal). Azoles and allylamines further target the membrane by inhibiting enzymes in the ergosterol biosynthetic pathway, such as lanosterol 14-alpha-demethylase and squalene epoxidase (PubChem: Fluconazole Mechanism; UniProt: Lanosterol 14-alpha-demethylase). These targets are vital for managing systemic and superficial fungal infections, though challenges like drug resistance and host toxicity remain significant (NCBI: Fungal Cell Wall; Wikipedia: Antifungal).
Inhibition of 1,3-beta-D-glucan synthase (echinocandins), direct binding to ergosterol to create trans-membrane pores (polyenes), and inhibition of ergosterol biosynthesis via lanosterol 14-alpha-demethylase (azoles) or squalene epoxidase (allylamines).
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal cell wall and cell membrane.